BR0114021A - 4-amino-quinazolinas - Google Patents

4-amino-quinazolinas

Info

Publication number
BR0114021A
BR0114021A BR0114021-3A BR0114021A BR0114021A BR 0114021 A BR0114021 A BR 0114021A BR 0114021 A BR0114021 A BR 0114021A BR 0114021 A BR0114021 A BR 0114021A
Authority
BR
Brazil
Prior art keywords
quinazolines
amino
salts
quinazolins
ibix
Prior art date
Application number
BR0114021-3A
Other languages
English (en)
Inventor
Werner Mederski
Devant Ralf
Gerhard Barnickel
Sabine Bernotat-Danielowski
James Vickers
Bertram Cezanne
Daljit Dhanoa
Bao-Ping Zhao
James Rinker
Mark R Player
Edward Jaeger
Richard Soll
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0114021A publication Critical patent/BR0114021A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"4-AMINO-QUINAZOLINAS". A presente invenção refere-se a quinazolinas da fórmula I, na qual R, R^ 1^, R^ 2^, R^ 3^, R^ 4^ e Y têm o significado indicado na reivindicação 1 da Patente e seus sais ou solvatos como antagonistas da glicoproteína IbIX.
BR0114021-3A 2000-09-20 2001-09-17 4-amino-quinazolinas BR0114021A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66611700A 2000-09-20 2000-09-20
PCT/EP2001/010704 WO2002024666A2 (en) 2000-09-20 2001-09-17 4-amino-quinazolines

Publications (1)

Publication Number Publication Date
BR0114021A true BR0114021A (pt) 2003-08-19

Family

ID=24672900

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114021-3A BR0114021A (pt) 2000-09-20 2001-09-17 4-amino-quinazolinas

Country Status (14)

Country Link
US (1) US20040044204A1 (pt)
EP (1) EP1318985A2 (pt)
JP (1) JP2004509875A (pt)
KR (1) KR20030061807A (pt)
CN (1) CN1474816A (pt)
AU (1) AU2002213923A1 (pt)
BR (1) BR0114021A (pt)
CA (1) CA2422560A1 (pt)
HU (1) HUP0302429A3 (pt)
MX (1) MXPA03002411A (pt)
NO (1) NO20031267L (pt)
PL (1) PL359918A1 (pt)
WO (1) WO2002024666A2 (pt)
ZA (1) ZA200303069B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60132484T2 (de) * 2000-11-02 2009-01-15 Nippon Shinyaku Co., Ltd. Chinazolinderivate und -arzneimittel
PE20030008A1 (es) 2001-06-19 2003-01-22 Bristol Myers Squibb Co Inhibidores duales de pde 7 y pde 4
US7829566B2 (en) 2001-09-17 2010-11-09 Werner Mederski 4-amino-quinazolines
AU2003255482A1 (en) * 2002-10-02 2004-04-23 Merck Patent Gmbh Use of 4 amino-quinazolines as anti cancer agents
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US20050209438A1 (en) * 2004-03-19 2005-09-22 Browne Edward P Starter feed stream acidification in DMC-catalyzed process
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
US7473884B2 (en) * 2005-04-21 2009-01-06 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. Orientation determination utilizing a cordless device
KR100728763B1 (ko) * 2005-12-13 2007-06-19 주식회사 에스티넷 Ｐｏｎ 또는 ａｏｎ 방식의 방송/통신 융합 ｆｔｔｈ시스템
NZ598516A (en) 2009-09-03 2013-02-22 Bristol Myers Squibb Co Quinazolines as potassium ion channel inhibitors
CN102146076B (zh) * 2010-02-05 2013-12-25 陕西师范大学 苯胺喹唑啉衍生物及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US44442A (en) * 1864-09-27 Dayid nelson
US14679A (en) * 1856-04-15 Joel h
US55514A (en) * 1866-06-12 Improved machine for tunneling rock
US3974277A (en) * 1974-09-06 1976-08-10 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines as growth promotants and feed efficiency enhancing agents
US3970648A (en) * 1974-09-06 1976-07-20 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines
US3973021A (en) * 1974-09-06 1976-08-03 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(phydroxyanilino)quinazoline as a bactericide
US4642347A (en) * 1985-05-21 1987-02-10 American Home Products Corporation 3(2-quinolinylalkoxy)phenols
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
JP3531944B2 (ja) * 1991-02-07 2004-05-31 アベンティス・ファーマ・ソシエテ・アノニム 新規のベンジル基で置換された窒素系二環式誘導体及びその製造方法
US6004979A (en) * 1991-02-07 1999-12-21 Hoechst Marion Roussel Nitrogenous bicycles
US5245036A (en) * 1992-05-07 1993-09-14 Dowelanco Process for the preparation of 4-phenoxyquinoline compounds
US5972598A (en) * 1992-09-17 1999-10-26 Board Of Trustess Of The University Of Illinois Methods for preventing multidrug resistance in cancer cells
EP1195372A1 (en) * 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
US5840695A (en) * 1994-10-07 1998-11-24 Heska Corporation Ectoparasite saliva proteins and apparatus to collect such proteins
US5598994A (en) * 1995-06-29 1997-02-04 Panduit Corp. Stud engaging device
US5906819A (en) * 1995-11-20 1999-05-25 Kirin Beer Kabushiki Kaisha Rho target protein Rho-kinase
DE19608653A1 (de) * 1996-03-06 1997-09-11 Thomae Gmbh Dr K Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
AU3766897A (en) * 1996-07-13 1998-02-09 Glaxo Group Limited Fused heterocyclic compounds as protein tyrosine kinase inhibitors
DK0956865T4 (da) * 1996-08-12 2010-11-22 Mitsubishi Tanabe Pharma Corp Medikamenter omfattende Rho-kinaseinhibitor
US5885803A (en) * 1997-06-19 1999-03-23 Incyte Pharmaceuticals, Inc. Disease associated protein kinases
ZA986729B (en) * 1997-07-29 1999-02-02 Warner Lambert Co Irreversible inhibitors of tyrosine kinases
AU8748798A (en) * 1997-08-22 1999-03-16 Kyowa Hakko Kogyo Co. Ltd. 4-aminoquinazoline derivatives
US20020025968A1 (en) * 1998-04-15 2002-02-28 Rifat Pamukcu Method for inhibiting neoplastic cells and related conditions by exposure to 4-aminoquinazoline derivatives
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
US6080747A (en) * 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
US6890930B1 (en) * 1999-09-28 2005-05-10 3-Dimensional Pharmaceuticals, Inc. Quinazolinones
EP1306372B1 (en) * 2000-03-31 2009-11-18 Nippon Shinyaku Co., Ltd. Heterocycle derivatives and drugs

Also Published As

Publication number Publication date
EP1318985A2 (en) 2003-06-18
PL359918A1 (en) 2004-09-06
ZA200303069B (en) 2004-07-19
NO20031267L (no) 2003-05-19
KR20030061807A (ko) 2003-07-22
MXPA03002411A (es) 2003-06-19
CA2422560A1 (en) 2002-03-28
US20040044204A1 (en) 2004-03-04
HUP0302429A3 (en) 2004-01-28
WO2002024666A3 (en) 2002-09-26
JP2004509875A (ja) 2004-04-02
WO2002024666A2 (en) 2002-03-28
CN1474816A (zh) 2004-02-11
NO20031267D0 (no) 2003-03-19
AU2002213923A1 (en) 2002-04-02
HUP0302429A2 (hu) 2003-10-28

Similar Documents

Publication Publication Date Title
BR0114020A (pt) 4-amino-quinazolinas
BR0114021A (pt) 4-amino-quinazolinas
CR7017A (es) Carboxamidas como fungicidas en agricultura
BR0205889A (pt) Pirazolopirimidinas como agentes tepapêuticos
BR9815518A (pt) Agentes antibacterianos de oxazolidinona tendo funcionalidade de tiocarbonila
EE05105B1 (et) Fenlfenantridiinid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
BR0205890A (pt) Pirazolopirimidinas como agentes terapêuticos
BR0111878A (pt) N-ureido-(heterociclo-alquil)-piperidinas como moduladores da atividade de receptores de quimiocinas
BRPI0512958A (pt) antagonistas de nk1
DK1392666T3 (da) Biologisk aktive methylenblåt-derivater
BR0209440A (pt) Sulfonamidas
BR0017026A (pt) Lipeptìdeos como agentes antibacterianos
BR9813477A (pt) Derivados de benzamidina
BRPI0410995A (pt) derivados de n-alquinil-2-(arilóxi substituìdo)alquiltioamida como fungicidas
BR9912299A (pt) Derivados de bifenila
BR0014311A (pt) Quinazolinonas
CY1108281T1 (el) 17-α-υποκατασταθεισα-11-β-υποκατασταθεισα-4-αρυλ και 21-υποκατασταθεισα 19-νορπρεγναδιενοδιονη ως νεοι αντι-προεμμηνορροϊκοι παραγοντες.
TR200402442T4 (tr) Pirolidin ve piperidin türevleri ve bunların nörodejeneratif bozuklukların tedavisinde kullanımları
ATE236657T1 (de) Konjugat, umfassend einen folsäureantagonisten und einen träger
BR9916680A (pt) Derivados da 3,3-biarilpiperidina e2,2-biarilmorfolina
BR9915611A (pt) Benzo [de] isoquinolina-1,3-dionas substituìdas
BR0212031A (pt) Preparados de combinação de derivados de 1,1-dióxido de 1-4-benzotiepina com outras substâncias ativas e seu emprego
BRPI0406704A (pt) Antagonistas de 5ht~7~ e agonistas inversos
BR0014294A (pt) Quinazolinonas
BR9911353A (pt) Compostos benzazol e seu uso

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]